Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA ProjectGiordano Madeddu, for the CISAI Group, Elena Ricci et al.|Biomedicine & Pharmacotherapy|2007Cited by 74
Metabolic Syndrome: A Real Threat for HIV-Positive Patients?Paolo Bonfanti, Tiziana Quirino, Elena Ricci et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 29
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E StudyAmedeo Capetti, Giuliano Rizzardini, Paola Meraviglia et al.|International Journal of Antimicrobial Agents|2013Cited by 17
96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian ExperienceAmedeo Capetti, Giuliano Rizzardini, Simona Landonio et al.|PLoS ONE|2012Cited by 13
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].Giordano Madeddu, Paolo Bonfanti, Tiziana Quirino et al.|PubMed|2006Cited by 9